Helpdesks will operate at the EMCDDA (Lisbon) on the day of the launch to answer journalists’ questions.
Before 15 November (for details on the launch, scheduling interviews, etc), please ask for the press office at the following numbers:
Tel. ++ 351 211 21 02 00 (general)
Tel. ++ 351 211 21 02 40 (Maria José Louro)
From 15 November onwards, Annual report-related calls will be dispatched according to questions and requests for interviews, please contact the following number:
Tel. ++ 351 211 21 02 25 (Liesbeth Vandam)
Helpdesks at the Reitox focal points will answer country-specific queries.
The EU drugs agency will present its annual assessment of Europe’s drugs problem in its Annual report 2011 to be released on 15 November in Lisbon. The report, the agency’s flagship publication, provides the latest data and commentary on the drug situation across the 27 EU Member States, Croatia, Turkey and Norway. Key challenges are discussed along with some of the promising practices used to address drug problems today. Where possible, European data are placed in a global context.
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon.
This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented.
This Selected issue provides an exploratory European overview of costs associated with treatment for drug dependence. The cost of drug treatment in Europe is looked at from two main angles in this report.
Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership.
This report focuses on the topic of improving treatment quality by the development of guidelines.
This paper presents findings from the two most recent rapid assessments of the online availability of substances.